Robert Flisiak
Expertise in
13
conditions

Robert Flisiak

14 Żurawia St, 
Bialystok, PD, PL 
Expertise in
13
conditions
14 Żurawia St, 
Bialystok, PD, PL 

Overview

Robert Flisiak practices practicing medicine in Bialystok, Poland.

Mr. Flisiak is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Hepatitis, Hepatitis C, Hepatitis B, Liver Transplant, and Kidney Transplant.

He is actively involved in clinical research, co-authoring 332 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

14 Żurawia St, Bialystok, PD 15540, Poland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
Enrollment Status: Terminated
Publish Date: October 01, 2024
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 3
Real World Evidence (RWE) of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Poland (HCV RWE PMOS)
Real World Evidence (RWE) of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Poland (HCV RWE PMOS)
Enrollment Status: Completed
Publish Date: October 17, 2018
View 1 Less Clinical Trial

331 Total Publications

Trends in Comorbidities and Fatalities Among First-Time Hepatitis B Hospitalizations in Poland (2012-2023).
Trends in Comorbidities and Fatalities Among First-Time Hepatitis B Hospitalizations in Poland (2012-2023).
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: September 03, 2026

Frequently Asked Questions about Robert Flisiak

Is Robert Flisiak a top-rated expert for Hepatitis?

MediFind is an objective health platform that identifies experts based on real-world data. Robert Flisiak is classified as an Elite expert for Hepatitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Robert Flisiak participate in research or clinical trials?

Yes. Robert Flisiak has published 331 articles and abstracts on conditions like Hepatitis. You can view a list of Robert Flisiak's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Flisiak's expertise for a condition
ConditionClose
View All 7 Advanced Conditions
View All 30 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile